Reshaping the HIV treatment and prevention landscape

New GSK financial reporting considerations Vaccines IFRS income statement Operating segments Commercial Revenue and Adjusted OP Product Area Revenues Specialty Medicines General Medicines Revenue and Revenue by key product R&D Adjusted OP Corporate/other/ adjusting items OP gsk 118

View entire presentation